Clinical Trial Update: Grazax Asthma Prevention [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Grazax for asthma prevention in allergic rhinitis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• GRAZAX (birch pollen sublingual immunotherapy tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED